Minimal residual disease monitoring in acute myeloid leukaemia: are we ready to move from bone marrow to peripheral blood?

被引：6
|
作者：
Malagola, Michele [1 ,2 ]
Bernardi, Simona [1 ,2 ,3 ]
Polverelli, Nicola [1 ,2 ]
Russo, Domenico [1 ,2 ]
机构：
[1] Univ Brescia, Dept Clin & Expt Sci, Chair Hematol, Brescia, Italy
[2] ASST Spedali Civili Brescia, Unit Blood Dis & Stem Cell Transplantat, Brescia, Italy
[3] ASST Spedali Civili Brescia, Hematol Res AIL Ctr, CREA Lab, Brescia, Italy
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2020年 / 190卷 / 02期
关键词：
FLOW-CYTOMETRY;
D O I：
10.1111/bjh.16579
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：135 / 136
页数：2
相关论文
共 50 条
  • [1] Monitoring of minimal residual disease in acute myeloid leukemia using peripheral blood as an alternative source to bone marrow
    Maurillo, L.
    Buccisano, F.
    Del Poeta, G.
    Spagnoli, A.
    Neri, B.
    Del Principe, M. I.
    Cupelli, L.
    Luciano, F.
    De Fabritiis, P.
    Amadori, S.
    Venditti, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 183 - 184
  • [2] Monitoring of minimal residual disease in adult acute myeloid leukemia using peripheral blood as an alternative source to bone marrow
    Maurillo, Luca
    Buccisano, Francesco
    Spagnoli, Alessandra
    Del Poeta, Giovanni
    Panetta, Paola
    Neri, Benedetta
    Del Principe, Maria Ilaria
    Mazzone, Carla
    Consalvo, Maria Irno
    Tamburini, Anna
    Ottaviani, Licia
    Fraboni, Daniela
    Sarlo, Chiara
    De Fabritiis, Paolo
    Amadori, Sergio
    Venditti, Adriano
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (05): : 605 - 611
  • [3] COMPARISON OF BONE MARROW VERSUS PERIPHERAL BLOOD MINIMAL RESIDUAL DISEASE IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKAEMIA
    Tawana, Kiran
    Randall, Katie
    Jesson, Jenny
    Eyre, Lisa
    Whitehouse, Melanie
    Lawson, Sarah
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2011, 80B (06) : 401 - 402
  • [4] Monitoring of minimal residual disease (MRD) in acute myeloid leukemia using peripheral blood (PB) as an alternative source to bone marrow (BM).
    Maurillo, L
    Buccisano, F
    Neri, B
    Mazzone, C
    Del Poeta, G
    Ottaviani, L
    Niscola, P
    Del Principe, I
    Tamburini, A
    Consalvo, MI
    Lo Coco, F
    Amadori, S
    Venditti, A
    BLOOD, 2005, 106 (11) : 664A - 664A
  • [5] Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia
    Zeijlemaker, W.
    Kelder, A.
    Oussoren-Brockhoff, Y. J. M.
    Scholten, W. J.
    Snel, A. N.
    Veldhuizen, D.
    Cloos, J.
    Ossenkoppele, G. J.
    Schuurhuis, G. J.
    LEUKEMIA, 2016, 30 (03) : 708 - 715
  • [6] Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia
    W Zeijlemaker
    A Kelder
    Y J M Oussoren-Brockhoff
    W J Scholten
    A N Snel
    D Veldhuizen
    J Cloos
    G J Ossenkoppele
    G J Schuurhuis
    Leukemia, 2016, 30 : 708 - 715
  • [7] Minimal residual disease detection for acute lymphoblastic leukaemia in peripheral blood-Are we there yet?
    Trka, Jan
    Fronkova, Eva
    BRITISH JOURNAL OF HAEMATOLOGY, 2024,
  • [8] Minimal residual disease in acute myeloid leukaemia
    Yin, JAL
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2002, 15 (01) : 119 - 135
  • [9] Minimal residual disease in acute myeloid leukaemia
    Hourigan, Christopher S.
    Karp, Judith E.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2013, 10 (08) : 460 - 471
  • [10] Minimal residual disease in acute myeloid leukaemia
    Christopher S. Hourigan
    Judith E. Karp
    Nature Reviews Clinical Oncology, 2013, 10 : 460 - 471
12345